RefluxII: Comparison of Total and Partial Fundoplication During Surgery of Patients With Gastroesophageal Reflux Disease

Sponsor
Karolinska Institutet (Other)
Overall Status
Completed
CT.gov ID
NCT03659487
Collaborator
(none)
460
2
203

Study Details

Study Description

Brief Summary

460 patients who are scheduled for surgical treatment of gastroesophageal reflux disease (GERD) participate in the study following the usual preoperative Clinical routines (Medical history, endoscopy with biopsies, esophageal manometry with 24 hour pH (acidity) registration ). Patients are randomized to fundoplication according to Nissen or modified Toupet. Postoperatively, patients are monitored after 6 weeks 12, 36, 24 and 60 months.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Nissen
  • Procedure: Toupét
N/A

Detailed Description

Patients aged 18-75 years planned for elective surgical treatment of GERD participate in the study. Patients with recurrent reflux disease following prior surgery, ASA (American Society of Anesthesiologists (ASA) Physical Status") class> 3, paraesophageal herniating and / or major herniation without reflux and those with other contraindications against laparoscopic surgery are excluded. In addition, patient completes a QOL protocol. Patients in the study are randomized to laparoscopic fundoplication performed either with a 360 degrees (Nissen) alternatively 270 degree (modified Toupét). Both of these techniques are well established clinical routines. General intubation anesthesia is standardized to all study patients. Discharge from the hospital is typically on the first postoperative day. At a visit, after 6-8 weeks for clinical control, is a QOL protocol is completed as well. After 12 and 36 months, patients undergo upper endoscopy and manometry with 24 hour pH-registration and QOL protocol completion. The latter also occurs after 24 months and 60 months.

Study Design

Study Type:
Interventional
Actual Enrollment :
460 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Laparoscopic total (Nissen) vs posterior 270 degrees (Toupét) partial fundoplication for the treatment of gastroesophageal reflux disease.Laparoscopic total (Nissen) vs posterior 270 degrees (Toupét) partial fundoplication for the treatment of gastroesophageal reflux disease.
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparison of Total and Partial Fundoplication During Surgery of Patients With Gastroesophageal Reflux Disease
Actual Study Start Date :
Nov 1, 2001
Actual Primary Completion Date :
Apr 1, 2011
Actual Study Completion Date :
Oct 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Nissen

Surgery of GERD with 360 degrees total fundoplication

Procedure: Nissen
Laparoscopic total (Nissen) fundoplication

Active Comparator: Toupét

Surgery of GERD with 270 degrees partial fundoplication

Procedure: Toupét
Laparoscopic posterior 270 degrees partial fundoplication

Outcome Measures

Primary Outcome Measures

  1. Esophageal acid exposure [Change from baseline at 6 weeks, 12 and 36 month]

    24-hour pH measurement

Secondary Outcome Measures

  1. Recurrens rates [Change from baseline at 6 weeks, 12, 36 and 60 month]

    Medical journal or patients description

  2. Dysphagia scoring [Change from baseline at 6 weeks, 12, 36 and 60 month]

    Dysphagia for liquids and solids were recorded within a four-graded scale stating the frequency of dysphagia episodes with an arbitrary (empirical) cut off for clinical significance. The same dysphagia scoring was also used in a previous rct, from the same institution, comparing different types of antireflux procedures in open surgery.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • surgery treatment for GERD

  • laparoscopic surgery

Exclusion Criteria:
  • previous surgery for GERD

  • ASA classification >3

  • paraesophageal hernias or large hiatal

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Karolinska Institutet

Investigators

  • Principal Investigator: Anders Thorell, professor, Karolinska Institut

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Anders Thorell, Professor, Karolinska Institutet
ClinicalTrials.gov Identifier:
NCT03659487
Other Study ID Numbers:
  • EPN 225/01
First Posted:
Sep 6, 2018
Last Update Posted:
Oct 29, 2018
Last Verified:
Oct 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 29, 2018